Chlorproguanil/dapsone
Combination drug
From Wikipedia, the free encyclopedia
Chlorproguanil/dapsone (sold commercially as Lapdap) was a fixed dose antimalarial combination containing chlorproguanil and dapsone,[1] which act synergistically against malaria. The drug was withdrawn in 2008 following increasing evidence of toxicity in the form of haemolysis occurring in patients with G6PD deficiency.[2]
| Combination of | |
|---|---|
| Chlorproguanil | Antimalarial drug |
| Dapsone | Antibiotic |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
